Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.49 |
| ▸ | FAAH | O00519 | 5/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | FABP4 | P15090 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9187822 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL11278345 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL5606485 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL11275533 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL11275485 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL11272421 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL331855 | 0.91 | CES2 (0.38) | FAAHCES1CYP1A2HSD17B10 | |
| SCHEMBL11135669 | 0.89 | BBOX1 (0.36) | FAAHCES1 | |
| SCHEMBL5198018 | 0.81 | PPARG (0.54) | FABP3FAAHGMNNUSP2LMNA | |
| SCHEMBL18139069 | 0.80 | HTT (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4477365-A | ALKALI METAL HYDROXIDE, FATTY ACID SUBSTITUTED BETAINE, ALPHA-OLEFIN SULFONATE, AND HYDROTROPIC AGENT | MILES LABORATORIES, INC. (US) | 1984-10-16 | — | — | US | claimed |
| US-10894191-B2 | Golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2021-01-19 | — | — | US | disclosed |
| US-10888738-B2 | Golf ball resin composition and golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2021-01-12 | — | — | US | disclosed |
| US-10661124-B2 | Golf ball resin composition and golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2020-05-26 | — | — | US | disclosed |
| US-10195488-B2 | Golf ball resin composition and golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2019-02-05 | — | — | US | disclosed |
| US-10195489-B2 | Golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2019-02-05 | — | — | US | disclosed |
| US-20180353814-A1 | GOLF BALL RESIN COMPOSITION AND GOLF BALL | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2018-12-13 | — | — | US | disclosed |
| US-10086236-B2 | Golf ball resin composition and golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2018-10-02 | — | — | US | disclosed |
| US-10080924-B2 | Golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2018-09-25 | — | — | US | disclosed |
| US-20180243613-A1 | GOLF BALL RESIN COMPOSITION AND GOLF BALL | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2018-08-30 | — | — | US | disclosed |
| US-20130079178-A1 | GOLF BALL RESIN COMPOSITION AND GOLF BALL | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2013-03-28 | — | — | US | disclosed |
| US-6613866-B2 | Monomeric and polymeric urethane surfactants which are derived from linear, branched or aromatic compounds of synthetic or natural origin, preferably from tertiary amines and diisocyante compounds; cosmetics, dental care, toiletries | ALZO INTERNATIONAL INC. | 2003-09-02 | — | — | US | disclosed |
| EP-1162949-A4 | URETHANE SURFACTANTS AND THEIR USE IN PERSONAL CARE FORMULATIONS | ALZO INC (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20020015688-A1 | Urethane surfactants and their use in personal care formulations | ALZO, INC. | 2002-02-07 | — | — | US | disclosed |
| EP-1162949-A1 | URETHANE SURFACTANTS AND THEIR USE IN PERSONAL CARE FORMULATIONS | Alzo, Inc. (US) | 2001-12-19 | — | — | EP | disclosed |
| US-6315991-B1 | FOR USE IN COSMETICS, DENTAL CARE PRODUCTS AND TOILETRIES; FOR USE AS CONDITIONERS, ANTISTATS, DETANGLERS, FACILITATORS FOR EASE OF WET/DRY COMBING, AS EMULSIFIERS IN HAIR DYES | FLEET BANK, NATIONAL ASSOCIATION | 2001-11-13 | — | — | US | disclosed |
| WO-2000056285-A1 | URETHANE SURFACTANTS AND THEIR USE IN PERSONAL CARE FORMULATIONS | ALZO, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| EP-0116171-B1 | A CAUSTIC BASED AQUEOUS CLEANING COMPOSITION | MILES INC. (US) | 1988-09-28 | — | — | EP | disclosed |
| US-4477365-A | ALKALI METAL HYDROXIDE, FATTY ACID SUBSTITUTED BETAINE, ALPHA-OLEFIN SULFONATE, AND HYDROTROPIC AGENT | MILES LABORATORIES, INC. (US) | 1984-10-16 | — | — | US | disclosed |
| EP-0116171-A2 | A caustic based aqueous cleaning composition | MILES INC. (US) | 1984-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020015688-A1 | Urethane surfactants and their use in personal care formulations | POLR1C, XRCC5, UROD | FABP3 4752/4885FAAH 2667/4885CES1 3387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.